Carbonic anhydrase inhibitors: The first on-resin screening of a 4-sulfamoylphenylthiourea library

Journal of Medicinal Chemistry

Volumn 47, Issue 21, 2004, Pages 5224-5229

  Innocenti, Alessio ^a   Casini, Angela ^a   Alcaro, Maria C ^a   Papini, Anna M ^a   Scozzafava, Andrea ^a   Supuran, Claudiu T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 ISOTHIOCYANATOBENZENESULFONAMIDE; 4 SULFAMOYLPHENYLTHIOUREA DERIVATIVE; ACETAZOLAMIDE; ANTIGLAUCOMA AGENT; BRINZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; DICLOFENAMIDE; DORZOLAMIDE; ETHOXZOLAMIDE; INDISULAM; METHAZOLAMIDE; N [[[4 (AMINOSULFONYL)PHENYL]AMINO]THIOXOMETHYL]ALANINE; N [[[4 (AMINOSULFONYL)PHENYL]AMINO]THIOXOMETHYL]ASPARAGINE; N [[[4 (AMINOSULFONYL)PHENYL]AMINO]THIOXOMETHYL]GLUTAMINE; N [[[4 (AMINOSULFONYL)PHENYL]AMINO]THIOXOMETHYL]ISOLEUCINE; N [[[4 (AMINOSULFONYL)PHENYL]AMINO]THIOXOMETHYL]LEUCINE; N [[[4 (AMINOSULFONYL)PHENYL]AMINO]THIOXOMETHYL]METHIONINE; N [[[4 (AMINOSULFONYL)PHENYL]AMINO]THIOXOMETHYL]PHENYLALANINE; N [[[4 (AMINOSULFONYL)PHENYL]AMINO]THIOXOMETHYL]PROLINE; N [[[4 (AMINOSULFONYL)PHENYL]AMINO]THIOXOMETHYL]TRYPTOPHAN; N [[[4 (AMINOSULFONYL)PHENYL]AMINO]THIOXOMETHYL]VALINE; RESIN; THIOHYDANTOIN DERIVATIVE; THIOUREA DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG SCREENING; DRUG SYNTHESIS; ENZYME INHIBITION; HIGH THROUGHPUT SCREENING; SOLID PHASE SYNTHESIS;

ANTIGENS, NEOPLASM; CARBONIC ANHYDRASE I; CARBONIC ANHYDRASE II; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; COMBINATORIAL CHEMISTRY TECHNIQUES; DATABASES, FACTUAL; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES; THIOUREA;

EID: 4744371616     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm049692i     Document Type: Article

References (41)

1. (a) Supuran, C. T., Scozzafava, A., Conway, J., Eds. Carbonic anhydrase - its inhibitors and activators; CRC Press (Taylor and Francis Group): Boca Raton, FL, 2004; pp 1-363 and references therein.
2. (b) Supuran, C. T.; Scozzafava, A. Carbonic anhydrase inhibitors and their therapeutic potential. Exp. Opin. Ther. Patents 2000, 10, 575-600.
3. (c) Supuran, C. T.; Scozzafava, A.; Casini, A. Carbonic anhydrase inhibitors. Med. Res. Rev. 2003, 23, 146-189.
4. (d) Supuran, C. T.; Scozzafava, A. Carbonic anhydrase inhibitors. Curr. Med. Chem.: Immunol., Endocr. Metab. Agents 2001, 1, 61-97.
5. (a) Maren, T. H. The links among biochemistry, physiology and pharmacology in carbonic anhydrase mediated systems. In Carbonic Anhydrase - From Biochemistry and Genetics to Physiology and Clinical Medicine; Botré, F., Gros, G., Storey, B. T., Eds.; VCH: Weinheim, Germany, 1991; pp 186-207.
6. (b) Maren, T. H. The development of topical carbonic anhydrase inhibitors. J. Glaucoma 1995, 4, 49-62.
7. (c) Mincione, F.; Menabuoni, L.; Supuran, C. T. Clinical applications of carbonic anhydrase inhibitors in ophthalmology. In Carbonic anhydrase - Its inhibitors and activators; Supuran, C. T., Scozzafava, A., Conway J., Eds.; CRC Press: Boca Raton, FL, 2004; pp 243-254.
8. (a) Sugrue, M. F. Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors. Prog. Retinal Eye Res. 2000, 19, 87-112.
9. (b) Silver, L. H. Dose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt). Brinzolamide dose-response study group. Surv. Ophthalmol. 2000, 44 (Suppl. 2), 147-153.
10. (a) Owa, T.; Nagasu, T. Novel sulphonamide derivatives for the treatment of cancer. Exp. Opin. Ther. Patents 2000, 10, 1725-1740.
11. (b) Owa, T.; Yoshino, H.; Okauchi, T.; Yoshimatsu, K.; Ozawa, Y.; Sugi, N. H.; Nagasu, T.; Koyanagi, N.; Kitoh, K. Discovery of novel antitumor sulfonamides targeting G1 phase of the cell cycle. J. Med. Chem. 1999, 42, 3789-3799.
12. (c) Supuran, C. T. Indisulam - an anticancer sulfonamide in clinical development. Exp. Opin. Invest. Drugs 2003, 12, 283-287.
13. (d) Abbate, F.; Casini, A.; Owa, T.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: Indisulam (E7070) is a potent inhibitor of cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX. Bioorg. Med. Chem. Lett. 2004, 14, 217-223.
14. (a) Scozzafava, A.; Owa, T.; Mastrolorenzo, A.; Supuran, C. T. Anticancer and antiviral sulfonamides. Curr. Med. Chem. 2003, 10, 925-953.
15. (b) Casini, A.; Scozzafava, A.; Mastrolorenzo, A.; Supuran, C. T. Sulfonamides and sulfonylated derivatives as anticancer agents. Curr. Cancer Drug Targets 2002, 2, 55-75.
16. (a) Scozzafava, A.; Menabuoni, L.; Mincione, F.; Briganti, F.; Mincione, G.; Supuran, C. T. Carbonic anhydrase inhibitors: Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring? J. Med. Chem. 1999, 42, 2641-2650.
17. (b) Scozzafava, A.; Briganti, F.; Mincione, G.; Menabuoni, L.; Mincione, F.; Supuran, C. T. Carbonic anhydrase inhibitors: Synthesis of water-soluble, amino acyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route. J. Med. Chem. 1999, 42, 3690-3700.
18. (a) Borras, J.; Scozzafava, A.; Menabuoni, L.; Mincione, F.; Briganti, F.; Mincione, G.; Supuran, C. T. Carbonic anhydrase inhibitors: Synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring? Bioorg. Med. Chem. 1999, 7, 2397-2406.
19. (b) Renzi, G.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: Topical sulfonamide antiglaucoma agents incorporating secondary amine moieties. Bioorg. Med. Chem. Lett. 2000, 10, 673-676.
20. (c) Ilies, M.; Supuran, C. T.; Scozzafava, A.; Casini, A.; Mincione, F.; Menabuoni, L.; Caproiu, M. T.; Maganu, M.; Banciu, M. D. Carbonic anhydrase inhibitors. Sulfonamides incorporating furan-, thiophene- and pyrrole-carboxamido groups possess strong topical intraocular pressure lowering properties as aqueous suspensions. Bioorg. Med. Chem. 2000, 8, 2145-2155.
21. (a) Supuran, C. T.; Briganti, F.; Menabuoni, L.; Mincione, G.; Mincione, F.; Scozzafava, A. Carbonic anhydrase inhibitors. Part 78. Synthesis of water-soluble sulfonamides incorporating xe2-alanyl moieties, possessing long-lasting intraocular pressure lowering properties via the topical route. Eur. J. Med. Chem. 2000, 35, 309-321.
22. (b) Mincione, G.; Menabuoni, L.; Briganti, F.; Mincione, F.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Part 79. Synthesis and ocular pharmacology of topically acting sulfonamides incorporating GABA moieties in their molecule, with long-lasting intraocular pressure lowering properties. Eur. J. Pharm. Sci. 1999, 9, 185-199.
23. Supuran, C. T.; Briganti, F.; Tilli, S.; Chegwidden, W. R.; Scozzafava, A. Carbonic anhydrase inhibitors: Sulfonamides as antitumor agents? Bioorg. Med. Chem. 2001, 9, 703-714.
24. Casini, A.; Scozzafava, A.; Mincione, F.; Menabuoni, L.; Ilies, M. A.; Supuran, C. T. Carbonic anhydrase inhibitors: Water-soluble 4- sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects. J. Med. Chem. 2000, 43, 4884-4892.
25. McKee, R. L.; Bost, R. W. p-Substituted phenyl isothiocyanates and some related thioureas. J. Am. Chem. Soc. 1946, 68, 2506-2507.
26. Kaiser, E.; Colescott, R. L.; Bossinger, C. D.; Cook, P. I. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 1970, 34, 595-598.
27. (a) Edman, P. Method for determination of the amino acid sequence in peptides. Acta Chem. Scand. 1950, 4, 283-293.
28. (b) Edman, P.; Begg, G. A protein sequenator. Eur. J. Biochem. 1967, 1, 80-91.
29. Laursen, R. A. Solid-phase Edman degradation. An automatic peptide sequencer. Eur. J. Biochem. 1971, 20, 89-102.
30. Lam, K. S.; Lebl M. Combinatorial library based on the one-bead-one-compound concept. In Combinatorial peptide and nonpeptide libraries; Jung, G., Ed.; VCH: Weinheim, Germany, 1996; pp 173-201.
31. Pocker, Y.; Stone, J. T. The catalytic versatility of erythrocyte carbonic anhydrase. III. Kinetic studies of the enzyme-catalyzed hydrolysis of p-nitrophenyl acetate. Biochemistry 1967, 6, 668-678.
32. Lindskog, S.; Behravan, G.; Engstrand, C.; Foreman, C.; Jonsson, B. H.; Liang, Z.; Ren, X.; Xue, Y. Structure-function relations in human carbonic anhydrase II as studied by site-directed mutagenesis. In Carbonic anhydrase - From biochemistry and genetics to physiology and clinical medicine; Botrè, F., Gros, G., Storey, B. T., Eds.; VCH: Weinheim, 1991; pp 1-13.
33. Behravan, G., Jonsson, B. H., Lindskog, S. Fine tuning of the catalytic properties of carbonic anhydrase. Studies of a Thr200-His variant of human isoenzyme II. Eur. J. Biochem. 1990, 190, 351-357.
34. Khalifah, R. G.; Strader, D. J.; Bryant, S. H.; Gibson, S. M. Carbon-13 nuclear magnetic resonance probe of active site ionization of human carbonic anhydrase B. Biochemistry 1977, 16, 2241-2247.
35. Lindskog, S.; Coleman, J. E. The catalytic mechanism of carbonic anhydrase. Proc. Natl. Acad Sci. U.S.A. 1964, 70, 2505-2508.
36. Steiner, H.; Jonsson, B. H.; Lindskog, S. The catalytic mechanism of carbonic anhydrase. Hydrogen-isotope effects on the kinetic parameters of the human C isoenzyme. Eur. J. Biochem. 1975, 59, 253-259.
37. Vullo, D.; Franchi, M.; Gallori. E.; Antel, J.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides. J. Med. Chem. 2004, 47, 1272-1279.
38. (a) Winum, J. Y.; Vullo, D.; Casini, A.; Montero, J. L.; Scozzafava, A.; Supuran C. T. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors. J. Med. Chem. 2003, 46, 2197-2204.
39. (b) Winum, J. Y.; Vullo, D.; Casini, A.; Montero, J. L.; Scozzafava, A.; Supuran C. T. Carbonic anhydrase inhibitors: inhibition of transmembrane, tumor-associated isozyme IX, and cytosolic isozymes I and II with aliphatic sulfamates. J. Med. Chem. 2003, 46, 5471-5477.
40. (c) Pastorekova, S.; Casini, A.; Scozzafava, A.; Vullo, D.; Pastorek, J.; Supuran, C. T. Carbonic anhydrase inhibitors: The first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. Bioorg. Med. Chem. Lett. 2004, 14, 869-873.
41. (d) Casey, J. R.; Morgan, P. E.; Vullo, D.; Scozzafava, A.; Mastrolorenzo, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX. J. Med. Chem. 2004, 47, 2337-2347.